Participate in Research

Browse Clinical Trials
TRANSCEND-T2D-3 Weight Management Study for Adults with Type 2 Diabetes and Kidney Disease
Protocol: STUDY00008062
Full Title
A Phase 3, Randomized, Multicenter, Double-Blind Study to Investigate the Efficacy and Safety of Retatrutide Once Weekly Compared with Placebo in Adult Participants with Type 2 Diabetes, Moderate or Severe Renal Impairment with Inadequate Glycemic Control on Basal Insulin with or without Metformin and/or SGLT2 inhibitor (TRANSCEND-T2D-3)
Description
The University at Buffalo (UB) Department Medicine is conducting a study for adults that have been diagnosed with Type 2 Diabetes (T2D) and chronic kidney disease. The goal of the study is to see if the study drug (retatrutide) can help to control blood sugar levels and manage weight in people with T2D.

Participants will be enrolled in this study for about a year. After completing a screening period, eligible participants will be randomly assigned to either receive the study drug or a placebo (which looks like the study drug but contains no medicine). There is 3 times the chance you will receive the study drug compared to placebo. Throughout the study they will complete in-person and virtual study visits, physical exams, blood draws, urine collections, and surveys.

Participants will be paid for completing study visits.
Compensation: Yes
?
Compensation may include cash, checks, gift cards, debit cards, or incentives like gift baskets, technology items, or merchandise.
Eligibility
-Adults 18 years or older
-Have been diagnosed with Type 2 Diabetes (T2D) AND kidney disease
-Are using basal insulin alone or with metformin/SGLT2 inhibitors to treat their T2D
-Are not underweight
-Have a blood glucose (sugar) level (also known as HbA1C) of 7.0% to 10.5%
-Are fluent in English
Age Group: Adults
Principal Investigator: AJAY CHAUDHURI
Contact(s)
HUSAM GHANIM
ghanim@buffalo.edu
+1 716-881-8924

Want to Learn More?

Let us know how the study team can reach you. If you do not hear back within 2 business days, then reach out to the study team directly at the contact information above and someone will assist you.

Your information will be shared only with the research study team and administrative staff for recruitment and will remain confidential. Your information will be stored until study recruitment is closed. Should you no longer want this information to be provided in the aforementioned ways, please contact the study team directly.

Study teams can login to review submissions
Study Team Login